- Home
- FMST vs RDHL Comparison
FMST vs RDHL Comparison
Compare FMST & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMST
- RDHL
- Stock Information
- Founded
- FMST 2005
- RDHL 2009
- Country
- FMST Canada
- RDHL Israel
- Employees
- FMST N/A
- RDHL N/A
- Industry
- FMST Other Metals and Minerals
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- FMST Basic Materials
- RDHL Health Care
- Exchange
- FMST Nasdaq
- RDHL Nasdaq
- Market Cap
- FMST 39.6M
- RDHL 4.3M
- IPO Year
- FMST N/A
- RDHL N/A
- Fundamental
- Price
- FMST $2.61
- RDHL $2.15
- Analyst Decision
- FMST
- RDHL
- Analyst Count
- FMST 0
- RDHL 0
- Target Price
- FMST N/A
- RDHL N/A
- AVG Volume (30 Days)
- FMST 444.6K
- RDHL 18.2K
- Earning Date
- FMST 01-01-0001
- RDHL 08-28-2025
- Dividend Yield
- FMST N/A
- RDHL N/A
- EPS Growth
- FMST N/A
- RDHL N/A
- EPS
- FMST N/A
- RDHL N/A
- Revenue
- FMST N/A
- RDHL $8,042,999.00
- Revenue This Year
- FMST N/A
- RDHL $381.91
- Revenue Next Year
- FMST N/A
- RDHL N/A
- P/E Ratio
- FMST N/A
- RDHL N/A
- Revenue Growth
- FMST N/A
- RDHL 23.17
- 52 Week Low
- FMST $0.55
- RDHL $1.71
- 52 Week High
- FMST $5.74
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- FMST 43.51
- RDHL 64.10
- Support Level
- FMST $3.02
- RDHL $2.00
- Resistance Level
- FMST $3.38
- RDHL $2.08
- Average True Range (ATR)
- FMST 0.33
- RDHL 0.09
- MACD
- FMST -0.12
- RDHL 0.03
- Stochastic Oscillator
- FMST 6.78
- RDHL 100.00
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.